Evidence map›Paper›PMID 39105174›Full record

ReviewJournal of the Endocrine Society2024

Diabetes Stigma and Clinical Outcomes: An International Review.

Kelsey B Eitel, Catherine Pihoker, Catherine E Barrett, Alissa J Roberts

Abstract readReview
In one paragraph

Review in Journal of the Endocrine Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Type 1 diabetes stigma: A UK survey of adults living with type 1 diabetes.Diabetic medicine : a journal of the British Diabetic Association · 2026
    Observational
  5. Article
  6. Article
  7. Article
  8. Diabetes and Foot Health Among South Asian People Seeking Asylum in the United Kingdom: A Theory-Informed Scoping Review.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Diabetes advocacy in the Asia-Pacific region.Journal of diabetes investigation · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kelsey B EitelDepartment of Pediatrics, University of Washington, Seattle, WA 98105, USA.ORCID https://orcid.org/0000-0001-5310-1057
Catherine PihokerDepartment of Pediatrics, University of Washington, Seattle, WA 98105, USA.ORCID https://orcid.org/0000-0001-9074-7770
Catherine E BarrettCenters for Disease Control and Prevention, Atlanta, GA 30341, USA.ORCID https://orcid.org/0000-0002-2692-4194
Alissa J RobertsDepartment of Pediatrics, University of Washington, Seattle, WA 98105, USA.ORCID https://orcid.org/0000-0002-0221-6273

Funding

Diabetes, Obesity and Metabolism Training ProgramT32DK007247 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON, KRISTINA Marie UTZSCHNEIDER · 1986 to 2026
$10.0M
NIDDK NIH HHS T32 DK007247
6 · The paper itself

Abstract

Diabetes stigma is the social burden of living with diabetes. People with diabetes may experience or perceive an adverse social judgment, prejudice, or stereotype about living with diabetes at work, school, in healthcare settings, popular culture, or relationships. This review describes the methods that have been used to assess diabetes stigma, and explores the prevalence of diabetes stigma, associated sociodemographic and socioeconomic factors, cultural factors, and how diabetes stigma is associated with clinical outcomes, including HbA1c levels, diabetic ketoacidosis, severe hypoglycemia, and chronic complications, in addition to psychosocial complications in youth, adolescents, and adults with type 1 diabetes (T1D) and type 2 diabetes (T2D). The prevalence of diabetes stigma has been reported as high as 78% in adults with T1D, 70% in adults with T2D, 98% in youth and adolescents with T1D, and is unknown in youth and adolescents with T2D. Diabetes stigma has been associated with lower psychosocial functioning, decreased self-care behaviors, higher HbA1c levels, and higher frequency of diabetes complications in adults with T1D and T2D. In adolescents and young adults with T1D, diabetes stigma is associated with lower psychosocial functioning, higher HbA1c levels, and higher frequency of diabetic ketoacidosis and severe hypoglycemia episodes in addition to chronic complications. In youth and adolescents with T2D, one study demonstrated an association of diabetes stigma with lower psychosocial functioning, higher HbA1c levels, and presence of retinopathy. Gaps exist in our understanding of the mechanisms of diabetes stigma, particularly in youth and adolescents with T2D.

Indexed as

clinical outcomescomplicationsdiabetes-related stigmadiabetic ketoacidosisHbA1c

Identifiers

PMID39105174
PMCPMC11299019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.